Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia) by T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin

Get full text

Phase I Pharmacokinetics Study of Drug Areplivir® Zinc (INN: Favipiravir + Zinc Gluconate) (LLC "PROMOMED RUS", Russia) by T. N. Komarov, N. S. Bagaeva, K. K. Karnakova, O. A. Archakova, D. S. Shchelgacheva, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, A. V. Taganov, I. E. Shohin

Get full text

Russian development for drug independence in endocrinology: comparative analysis of bioequivalence, safety and tolerability of the first domestic liraglutide by A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, S. M. Noskov

Get full text

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS by L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, P. A. Bely, V. F. Pavelkina, N. A. Pyataev, A. Yu. Ivanova, G. V. Rodoman, N. E. Kostina, V. B. Filimonov, E. N. Simakina, D. A. Bystritsky, A. S. Agafyina, K. N. Koryanova, D. Yu. Pushkar

Get full text

Comparative analysis of physicochemical properties, bioequivalence, safety and tolerability of the first domestic semaglutide by A. S. Ametov, I. E. Shokhin, E. A. Rogozhina, T. G. Bodrova, M. E. Nevretdinova, P. A. Bely, K. Ya. Zaslavskaya, V. S. Scherbakova, D. V. Kurkin, K. N. Koryanova, E. S. Mishchenko, E. Yu. Kesova, E. D. Kozlov, E. S. Samoshkina, D. N. Andreev, Yu. G. Kazaishvili, S. M. Noskov, L. A. Balykova

Get full text